BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Biocon Biologics to Acquire Viatris' Biosimilar Assets for Up to US$3.335 Billion in Cash and Equity

Biocon Biologics Ltd., a subsidiary of Biocon Ltd. (BSE: 532523) (NSE: BIOCON), has entered into a definitive agreement with its partner Viatris Inc. (NASD...

March 03, 2022 | News

MediBuddy Raises USD 125 Million in Series C Funding

MediBuddy, India's largest end-to-end digital healthcare platform, has raised USD 125 million in Series C funding from Quadria Cap...

February 25, 2022 | News

Molecule partners to develop Web3-based ecosystem addressing inefficiencies in biopharma R&D

VitaDAO and Molecule collaboratively source geroscience assets and finance R&D at universities, institutes, and biotech companies. VitaDAO has a worldw...

February 22, 2022 | News

Formus Labs Raises $5 Million to Automate Orthopedic Surgery Planning

Formus combines AI and biomechanics to empower orthopedic surgeons with fully interactive 3D models to optimize the preoperative planning process AUCKLAND...

February 03, 2022 | News

WAPG aims to create highly practical advantages to science start-ups

Today, We are Pioneer Group (WAPG) launches new nationwide partnerships with Leyton, the UK's largest innovation funding consultancy, and leading UK law ...

January 27, 2022 | News

Venus Medtech Concludes Acquisition of 100% Equity Interest in Cardiovalve

As of today, Cardiovalve becomes a member of the global operation team of Venus Medtech officially, which will accelerate the international footprint of it...

January 27, 2022 | News

Samsung Biologics Reports Fourth Quarter & Fiscal Year 2021 Financial Results

Q4'21 revenue of KRW 444.3 billion increased 18% compared to Q4'20. Q4'21 operating profit of KRW 128.8 billion increased 39% compar...

January 25, 2022 | News

Liminal BioSciences Announces Strategic Priorities for 2022

"2021 has been an important year for us: we have simplified our business strategy and created a liquidity reserve that will allow us to focus our resources...

January 24, 2022 | News

ReviR Therapeutics Raises ~$20M in Pre-A Financing

The funds will be used to advance the company's voyageR™ discovery platform, which integrates machine learning and RNA exploration at scale to i...

January 18, 2022 | News

Cellusion Raises 1.1B JPY to Advance Japan and Global Clinical Trials

Cellusion Inc., a regenerative medicine startup aiming to solve the global Corneal transplant waiting list problem with a unique differentiation induction ...

January 10, 2022 | News

Virtue Diagnostics closes $100 million Series B Funding

Virtue Diagnostics is a global, platform-based IVD (In Vitro Diagnostic) company focusing on providing affordable clinical solutions at all disease stages ...

January 06, 2022 | News

Novo Nordisk Announces Completion of Dicerna Pharmaceuticals Acquisition

Following the expiration of Novo Nordisk’s cash tender offer for Dicerna, Novo Nordisk has today acquired all outstanding shares of common stock of D...

December 29, 2021 | News

Syntach AB awarded an EU grant of € 2.5 million

Over 60 million people suffer from heart failure, and it is one of the most common causes of death globally. A cardiac support system can prolong and save ...

December 21, 2021 | News

Alembic Pharma announces seed round investment in RIGImmune

India based Alembic Pharmaceuticals has made a strategic investment in RIGImmune, a biopharmaceutical research company co-founded by two prominent Yale Uni...

December 13, 2021 | Opinion

Stay Connected